Guanabenz shows promise in slowing vanishing white matter disease progression in children
Here's what it means for you.
This breakthrough could reshape treatment approaches for rare childhood neurological disorders.
What happened
A clinical trial suggests that guanabenz, a blood pressure medication, may slow the progression of vanishing white matter disease in children.
The Context
- VWM disease is rare: It affects approximately 1 in 100,000 births globally, leading to severe cognitive and motor decline.
- No prior treatments: Before this trial, no pharmacological interventions had shown clinical benefits for VWM in humans.
- Ongoing research: Amsterdam UMC is conducting follow-up studies to assess long-term effects and optimal dosing.
The Number
— This statistic highlights the rarity of VWM disease, emphasizing the significance of any potential treatment advancements for affected families and healthcare professionals.
Takeaway
As research continues, the findings may pave the way for new therapeutic strategies in pediatric neurology.
UAE-based newspaper covering Gulf politics, society, and international developments.
"Gulf News is one of the UAE’s most prominent English-language publications."
— A47 Editor
Existing blood pressure drug may slow rare childhood brain disease: Study
A recent study suggests that an existing blood pressure drug may have the potential to slow the progression of a rare childhood brain disease. This finding could open new avenues for treatment options in pediatric neurology, particularly for conditio...
A curated Gulf News feed featuring major stories across news, business, opinion, and lifestyle.
"Gulf News is a major UAE newspaper whose featured stories feed reflects a broad editorial mix shaped for a Gulf audience."
— A47 Editor
Existing blood pressure drug may slow rare childhood brain disease: Study
A recent study suggests that an existing blood pressure drug may have the potential to slow the progression of a rare childhood brain disease. This finding could open new avenues for treatment options in pediatric neurology, particularly for conditio...
Health, medicine, wellness, and public health coverage with a UAE angle.
"Emirates 24|7 health coverage leans toward accessible reporting on healthcare updates, medical milestones, and wellness topics."
— A47 Editor
Existing blood pressure drug shows promise in slowing rare childhood brain disease, study finds
A study led by researchers at Amsterdam University Medical Centers has found that guanabenz, an existing blood pressure medication, may slow the progression of vanishing white matter (VWM) disease, a rare and often fatal neurodegenerative disorder af...
Arabic-language political and world news coverage for UAE readers.
"Emarat Al Youm world coverage usually presents international developments through a UAE and Arab audience lens."
— A47 Editor
دراسة حديثة: دواء لعلاج ضغط الدم قد يبطئ تطور مرض دماغي نادر ومميت عند الأطفال دراسة حديثة: دواء لعلاج ضغط الدم قد يبطئ تطور مرض دماغي نادر ومميت عند الأطفال
A recent study conducted by the Amsterdam Medical Centers in the Netherlands has revealed that a medication currently used to treat high blood pressure may help slow the progression of a rare and fatal brain disease in children. This finding highligh...